Welcome to our dedicated page for Forian SEC filings (Ticker: FORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Forian Inc. (FORA) SEC filings page on Stock Titan provides access to the company’s official regulatory documents filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer in the data processing and healthcare analytics space, Forian uses these filings to report its financial condition, governance matters, strategic transactions and other material events related to its operations in life sciences, healthcare and financial services analytics.
Through periodic reports such as the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, Forian presents audited and unaudited financial statements, discussions of results from continuing operations, information on discontinued operations, and details about its large-scale healthcare data assets and information products. These filings also include sections like “Risk Factors” that the company references in its news releases when discussing uncertainties related to its strategy, data assets and market environment.
Current Reports on Form 8-K document specific material events. Forian has used 8-K filings to disclose changes in independent registered public accounting firms, including the dismissal of CBIZ CPAs P.C. and the appointment of BDO USA, P.C., along with discussion of previously identified material weaknesses in internal control over financial reporting and related restatements. Other 8-Ks report financial results for particular quarters and describe proposals and governance actions, such as the Board’s receipt of an unsolicited, preliminary, non-binding proposal to take the company private and the formation of a Special Committee to evaluate that proposal.
Proxy materials, including the Definitive Proxy Statement (DEF 14A) filed on December 15, 2025, provide insight into Forian’s corporate governance and strategic considerations. In that proxy statement, the company calls a Special Meeting of Stockholders to vote on redomiciling from Delaware to Maryland through a statutory conversion and on potential adjournments of the meeting to solicit additional proxies. The document explains the Board’s and Special Committee’s reasoning and outlines how the redomiciliation relates to the evaluation of a take-private offer and other potential transactions.
On Stock Titan, these filings are updated as they appear on the SEC’s EDGAR system. AI-powered tools can help summarize lengthy documents, highlight key changes in financial performance, identify governance and control issues, and surface items such as revenue recognition discussions, internal control assessments and details of strategic proposals. Users can also review ownership and governance information contained in proxy statements and track how Forian’s disclosures evolve across reporting periods.
Consortium delivers non-binding going-private proposal for Forian Inc. A group of related investors led by Max C. Wygod and other reporting persons delivered an Offer Letter to Forian's board proposing to acquire all outstanding common stock not owned by the Consortium in a going-private transaction. The members executed a Consortium Agreement dated August 25, 2025, to govern cooperation; copies are filed as Exhibits 99.1 and 99.2. The filing reports individual beneficial ownership stakes, including Max C. Wygod (14.7%), Anthony Vuolo (12.9%), and other consortium-affiliated trusts and persons, calculated on 31,112,312 outstanding shares. The Offer Letter is non-binding, any transaction would require special committee approval and definitive documentation, financing sources are not finalized, and consummation would terminate Forian's Nasdaq registration if completed.
Amendment No. 1 to Schedule 13D for Forian Inc. (FORA) reports that a consortium including Max C. Wygod, Emily Bushnell, two Wygod family trusts and the Estate of Martin J. Wygod delivered a non-binding offer letter on August 25, 2025 proposing a going-private acquisition of all outstanding common stock not owned by the consortium. The filing states the consortium entered a Consortium Agreement governing cooperation and exclusivity in pursuing the Proposed Transaction. The consortium members collectively report up to 14.7% beneficial ownership (4,360,236 shares by Max Wygod) and individual holdings including 12.6% (3,932,533 shares) by Emily Bushnell and trust holdings of 5.0% and 4.8%. Funding is expected from personal resources, third-party financing and the company’s cash, but terms are not finalized. The Offer Letter is non-binding and any transaction would be conditioned on a disinterested special committee and definitive agreements.
Forian Inc. received an unsolicited, preliminary and non-binding proposal from a group led by founder, Executive Chairman and CEO Max Wygod to take the company private at $2.10 per share for the other shareholders. The group, which also includes inside directors Adam Dublin and Shahir Kassam-Adams, beneficially owns about 63% of Forian’s common stock.
The Board has formed a Special Committee of independent directors with its own advisors to evaluate the proposal and determine next steps. The proposal is subject to several conditions, including securing financing, negotiating satisfactory employment and definitive acquisition agreements, approval by the Special Committee, and completing an acquisition, including by tender, of a majority of Forian’s common shares.
Forian Inc. reported that board member Stanley S. Trotman, Jr. resigned from its board of directors and all related board committees, effective August 15, 2025. The company states that his resignation is not due to any disagreement or dispute with Forian regarding its operations, policies, or practices, indicating an amicable departure. Forian has not yet identified a replacement to fill the board vacancy created by his resignation.
Forian Inc. filed a Registration Statement on Form S-8 to register securities for its employee benefit/equity incentive plan. The filing incorporates the company’s certificate of incorporation and bylaws by reference, includes the Forian Inc. 2020 Equity Incentive Plan and a Second Amendment to that plan, and attaches legal opinion and consent letters from Duane Morris LLP and Marcum LLP. The filing grants powers of attorney to Max Wygod and Adam Dublin to sign and file amendments on behalf of the registrant, and it is signed by the company’s CEO, CFO and board members.
Forian Inc. reported revenue of $7,476,140 for the three months ended June 30, 2025, up $2,699,039 from the prior year period, driven by the Kyber acquisition and organic growth. The company reported a quarterly net income of $224,793 but a six‑month net loss of $(901,069). Cash and cash equivalents were $5,369,817 and marketable securities (U.S. Treasury bills) totaled $30,279,208, giving strong short‑term liquidity. Total assets were $48,462,637 with total liabilities of $17,520,976 and stockholders' equity of $30,941,661.
The Kyber acquisition generated a recorded bargain purchase gain of $1,204,830 and Kyber contributed $1,859,566 and $3,552,913 of revenue for the three and six months ended June 30, 2025. The company discloses vendor licensing risks from a supplier exit and ongoing contract obligations totaling $12,701,625.
Forian Inc. (FORA) furnished a press release on August 13, 2025 announcing its financial results for the quarter ended June 30, 2025. The press release is attached as Exhibit 99.1 and the Cover Page Interactive Data File is provided as Exhibit 104. The company states that the information furnished under Item 2.02, including Exhibit 99.1, is not deemed "filed" for purposes of Section 18 of the Exchange Act and will not be incorporated by reference in other filings except as expressly stated. The report is signed by Michael Vesey, Chief Financial Officer. The detailed financial figures are contained in the furnished press release rather than within the body of this Form 8-K.